Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A de Snoo

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The British Journal of Dermatology|November 19, 2009
Iatrogenic melanoma. Comment on: Melanoma epidemic: a midsummer night's dream?J I van der Rhee, W J Mooi, N A Kukutsch, et al.
Psycho-Oncology|March 4, 2005
Hereditary melanoma and predictive genetic testing: why not?S R Riedijk, F A de Snoo, S van Dijk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trialG Viale, L Slaets, J Bogaerts, et al.
Breast Cancer Research and Treatment|September 21, 2017
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trialG Viale, F A de Snoo, L Slaets, et al.
Breast Cancer Research and Treatment|November 22, 2014
Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysisC A Drukker, S G Elias, M V Nijenhuis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The British Journal of Dermatology|November 19, 2009
Iatrogenic melanoma. Comment on: Melanoma epidemic: a midsummer night's dream?J I van der Rhee, W J Mooi, N A Kukutsch, et al.
Psycho-Oncology|March 4, 2005
Hereditary melanoma and predictive genetic testing: why not?S R Riedijk, F A de Snoo, S van Dijk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2014
High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trialG Viale, L Slaets, J Bogaerts, et al.
Breast Cancer Research and Treatment|September 21, 2017
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trialG Viale, F A de Snoo, L Slaets, et al.
Breast Cancer Research and Treatment|November 22, 2014
Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysisC A Drukker, S G Elias, M V Nijenhuis, et al.
Pageof 1